Company Search:
Advanced Search
Sponsored Links
ProQR Therapeutics NV Company Snapshot
ProQR Therapeutics NV operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares ProQR Therapeutics NV with three other companies in this sector in the United States: AC Immune SA (2018 sales of $7.36 million of which 100% was Pharmaceutical), Aptinyx Inc ($6.57 million of which 100% was Pharmaceutical), and US Stem Cell Inc ($6.70 million ).

Sales Analysis. Sales increased substantially in 2018: ProQR Therapeutics NV reported sales of $6.79 million for the year ending December of 2018. This represents an increase of 298.6% versus 2017, when the company's sales were $1.70 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ProQR Therapeutics NV
  Stock Performance Chart for ProQR Therapeutics NV
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 6.36
(Figures in U.S. Dollars)
1 Week 2.9%   13 Weeks -10.5%  
4 Weeks -29.9%   52 Weeks -63.4%  
ProQR Therapeutics NV Key Data:
  Ticker: PRQR Country: Netherlands
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 6,787,956
(Year Ending Jan 2019).
Employees: 119
  Currency: U.S. Dollars Market Cap: 274,433,917
  Fiscal Yr Ends: December Shares Outstanding: 43,149,987
  Share Type: Common Closely Held Shares: 7,773,672
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.